Leukemia & Lymphoma, Volume 63, Issue 7 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 63, Issue 7 (2022)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Volume 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Article Commentary
Race (and ethnicity) matters in myelodysplastic syndromes
Sunil Girish Iyer & Mikkael Aaron Sekeres
Pages: 1519-1521
Published online: 28 Apr 2022
First Page PreviewforRace (and ethnicity) matters in myelodysplastic syndromes | Full Text | References | PDF (300.7 KB) | EPUB
  • 245 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Making the case for the case report – informing physicians of intracranial hypertension as an adverse event in tyrosine kinase inhibitor treated chronic myeloid leukemia patients
Nechama J. Lipton & Jeffrey H. Lipton
Pages: 1522-1523
Published online: 25 Mar 2022
CitationforMaking the case for the case report – informing physicians of intracranial hypertension as an adverse event in tyrosine kinase inhibitor treated chronic myeloid leukemia patients | Full Text | References | PDF (235.8 KB) | EPUB
  • 275 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Review
Relationship between leukaemic stem cells and hematopoietic stem cells and their clinical application
Samuel S. Y. Wang
Pages: 1524-1533
Published online: 22 Jan 2022
AbstractforRelationship between leukaemic stem cells and hematopoietic stem cells and their clinical application | Full Text | References | PDF (1.1 MB) | EPUB
  • 413 Views
  • 0 CrossRef citations
  • 0Altmetric
Review
Agent Orange and dioxin-induced myeloid leukemia: a weaponized vehicle of leukemogenesis
Rory M. Shallis & Steven D. Gore
Pages: 1534-1543
Published online: 02 Feb 2022
AbstractforAgent Orange and dioxin-induced myeloid leukemia: a weaponized vehicle of leukemogenesis | Full Text | References | PDF (883.2 KB) | EPUB
  • 798 Views
  • 1 CrossRef citations
  • 0Altmetric
Review
Systematic review reveals urgent need to homogenize endpoints choices and definitions in marginal zone lymphomas trials
Côme Bommier, Mathilde Ruggiu, Aymeric Monégier, Emanuele Zucca, Catherine Thieblemont & Jérôme Lambert
Pages: 1544-1555
Published online: 24 Feb 2022
AbstractforSystematic review reveals urgent need to homogenize endpoints choices and definitions in marginal zone lymphomas trials | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 257 Views
  • 2 CrossRef citations
  • 0Altmetric

Articles

Article
Baseline and progressive adipopenia in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features are associated with worse clinical outcomes
Marko Lucijanic, Renata Huzjan Korunic, Martina Sedinic, Stjepan Kovacevic, Armin Atic, Vlatko Pejsa & Rajko Kusec
Pages: 1556-1565
Published online: 02 Feb 2022
AbstractforBaseline and progressive adipopenia in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features are associated with worse clinical outcomes | Full Text | References | PDF (1.4 MB) | EPUB
  • 329 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia
Sarah Tettamanti, Maria Caterina Rotiroti, Greta Maria Paola Giordano Attianese, Silvia Arcangeli, Ronghua Zhang, Priyanka Banerjee, Giovanni Galletti, Sheighlah McManus, Massimiliano Mazza, Fabio Nicolini, Giovanni Martinelli, Cristina Ivan, Tania Veliz Rodriguez, Federica Barbaglio, Lydia Scarfò, Maurilio Ponzoni, William Wierda, Varsha Gandhi, Michael Keating, Andrea Biondi, Federico Caligaris-Cappio, Ettore Biagi, Paolo Ghia & Maria Teresa Sabrina Bertilaccio
Pages: 1566-1579
Published online: 08 Mar 2022
AbstractforLenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia | Full Text | References | PDF (3.2 MB) | EPUB
  • 999 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Characterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma
Tanya Siddiqi, Steven Coutre, Matthew McKinney, Paul M. Barr, Kerry Rogers, Ahmad Mokatrin, Rudy Valentino, Anita Szoke, Sanjay Deshpande, Angeline Zhu, Israel Arango-Hisijara, Kojo Osei-Bonsu, Michael Wang & Susan O’Brien
Pages: 1580-1588
Published online: 28 Feb 2022
AbstractforCharacterization of low-grade arthralgia, myalgia, and musculoskeletal pain with ibrutinib therapy: pooled analysis of clinical trials in patients with chronic lymphocytic leukemia and mantle cell lymphoma | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 2533 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Epstein-Barr virus copy number in peripheral blood mononuclear cells predicts prognosis in diffuse large B cell lymphoma
Jing Zhou, Jin Huang, Min Xiao, Ying Wang, Wei Zhang, Jie Wan, Yi Xiao & Jianfeng Zhou
Pages: 1589-1597
Published online: 11 Mar 2022
AbstractforEpstein-Barr virus copy number in peripheral blood mononuclear cells predicts prognosis in diffuse large B cell lymphoma | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 1764 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Hyperpigmented mycosis fungoides: a retrospective and comparative analysis with other subtypes of mycosis fungoides
Joon Min Jung, Mi Young Lee, Chong Hyun Won, Sung Eun Chang, Mi Woo Lee & Woo Jin Lee
Pages: 1598-1606
Published online: 24 Feb 2022
AbstractforHyperpigmented mycosis fungoides: a retrospective and comparative analysis with other subtypes of mycosis fungoides | Full Text | References | PDF (1.2 MB) | EPUB
  • 435 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study
Оlga L. Kochneva, Maria Kislova, Evgenya I. Zhelnova, Andrei A. Petrenko, Elena A. Baryakh, Konstantin V. Yatskov, Elena A. Dmitrieva, Elena N. Misurina, Konstantin E. Nikitin, Elena J. Vasilieva, Inna V. Samsonova, Vadim V. Ptushkin, Ancha Baranova & Eugene A. Nikitin
Pages: 1607-1616
Published online: 13 Feb 2022
AbstractforCOVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study | Full Text | References | PDF (2.6 MB) | EPUB | Supplemental
  • 387 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia
Brandy Perkins, Margaret Showel, Laura Schoch, Philip H. Imus, Theodoros Karantanos, Raluca Yonescu, Laura Morsberger, Gabriel Ghiaur, Douglas E. Gladstone & Richard J. Jones
Pages: 1617-1623
Published online: 27 Mar 2022
AbstractforCD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia | Full Text | References | PDF (1.1 MB) | EPUB
  • 305 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Prognostic significance of NOTCH1/FBXW7 mutations in pediatric T cell acute lymphoblastic leukemia: a study of minimal residual disease risk-directed CCLG-ALL 2008 treatment protocol
Yuan Yuan, Jun Li, Tian-Lin Xue, Hai-Rui Hu, Wei Lin, Shu-Guang Liu, Rui-Dong Zhang, Hu-Yong Zheng & Chao Gao
Pages: 1624-1633
Published online: 06 Feb 2022
AbstractforPrognostic significance of NOTCH1/FBXW7 mutations in pediatric T cell acute lymphoblastic leukemia: a study of minimal residual disease risk-directed CCLG-ALL 2008 treatment protocol | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 372 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Enhanced cytotoxicity of bisantrene when combined with venetoclax, panobinostat, decitabine and olaparib in acute myeloid leukemia cells
Benigno C. Valdez, Bin Yuan, David Murray, Yago Nieto, Uday Popat & Borje S. Andersson
Pages: 1634-1644
Published online: 20 Feb 2022
AbstractforEnhanced cytotoxicity of bisantrene when combined with venetoclax, panobinostat, decitabine and olaparib in acute myeloid leukemia cells | Full Text | References | PDF (2.4 MB) | EPUB
  • 2809 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia
Molly E. Graveno, Alison Carulli, Craig W. Freyer, Brendan L. Mangan, Robert Nietupski, Alison W. Loren, Noelle V. Frey, David L. Porter, Saar I. Gill, Elizabeth O. Hexner, Selina M. Luger, Mary Ellen Martin, Shannon R. McCurdy, Alexander E. Perl, Daria V. Babushok & Keith W. Pratz
Pages: 1645-1650
Published online: 08 Mar 2022
AbstractforVenetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia | Full Text | References | PDF (835.5 KB) | EPUB
  • 829 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
The impact of race and ethnicity on outcomes of patients with myelodysplastic syndromes: a population-based analysis
Suleyman Yasin Goksu, Muhammet Ozer, Busra B. Goksu, Rong Wang, Jude Khatib, Prapti A. Patel, Madhuri Vusirikala, Suzanne Cole, Ahmet Seyhanli, Robert H. Collins, Stephen Chung, Amer M. Zeidan & Yazan F. Madanat
Pages: 1651-1659
Published online: 08 Feb 2022
AbstractforThe impact of race and ethnicity on outcomes of patients with myelodysplastic syndromes: a population-based analysis | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 467 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Pembrolizumab for myelodysplastic syndromes after failure of hypomethylating agents in the phase 1b KEYNOTE-013 study
Guillermo Garcia-Manero, Vincent Ribrag, Yayan Zhang, Mohammed Farooqui, Patricia Marinello & B. Douglas Smith
Pages: 1660-1668
Published online: 04 Mar 2022
AbstractforPembrolizumab for myelodysplastic syndromes after failure of hypomethylating agents in the phase 1b KEYNOTE-013 study | Full Text | References | PDF (1,011.6 KB) | EPUB
  • 1534 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
Early versus late response to daratumumab-based triplet therapies in patients with multiple myeloma: a pooled analysis of trials POLLUX, CASTOR and MAIA
Jiasheng Wang, Raul Arroyo-Suarez, Srilatha Dasari, Kanithra Sekaran & William Tse
Pages: 1669-1677
Published online: 10 Feb 2022
AbstractforEarly versus late response to daratumumab-based triplet therapies in patients with multiple myeloma: a pooled analysis of trials POLLUX, CASTOR and MAIA | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 1192 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma
Ayako Muramatsu, Tsutomu Kobayashi, Yuka Kawaji-Kanayama, Hitoji Uchiyama, Nana Sasaki, Nobuhiko Uoshima, Mitsushige Nakao, Ryoichi Takahashi, Kazuho Shimura, Hiroto Kaneko, Miki Kiyota, Katsuya Wada, Yoshiaki Chinen, Koichi Hirakawa, Shin-ichi Fuchida, Chihiro Shimazaki, Shinsuke Mizutani, Taku Tsukamoto, Yuji Shimura, Masafumi Taniwaki, Satoshi Teramukai, Junya Kuroda & Kyoto Clinical Hematology Study Group (KOTOSG) Investigators
Pages: 1678-1685
Published online: 11 Feb 2022
AbstractforPretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 622 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation
Andrew Lin, Samantha Brown, Molly Maloy, Josel D. Ruiz, Sean Devlin, Lauren DeRespiris, Anthony Proli, Ann A. Jakubowski, Esperanza B. Papadopoulos, Craig S. Sauter, Roni Tamari, Hugo Castro-Malaspina, Brian Shaffer, Juliet Barker, Miguel A. Perales, Sergio A. Giralt & Boglarka Gyurkocza
Pages: 1686-1693
Published online: 10 Feb 2022
AbstractforImpact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation | Full Text | References | PDF (1 MB) | EPUB
  • 434 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation
Takashi Nagayama, Shin-ichiro Fujiwara, Tomohiro Kikuchi, Kaoru Onda, Rui Murahashi, Hirotomo Nakashima, Takashi Ikeda, Sae Matsuoka, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Tetsuaki Ban, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Ryoko Yamasaki, Kaoru Morita, Masahiro Ashizawa, Chihiro Yamamoto, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Ken Ohmine & Yoshinobu Kanda
Pages: 1694-1700
Published online: 14 Feb 2022
AbstractforImpact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation | Full Text | References | PDF (818 KB) | EPUB
  • 248 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Prediction of the risk for graft versus host disease after allogeneic hematopoietic stem cell transplantation in patients treated with mogamulizumab
Yuhei Kamada, Naosuke Arima, Maiko Hayashida, Daisuke Nakamura, Makoto Yoshimitsu & Kenji Ishitsuka
Pages: 1701-1707
Published online: 27 Feb 2022
AbstractforPrediction of the risk for graft versus host disease after allogeneic hematopoietic stem cell transplantation in patients treated with mogamulizumab | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 412 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Gender disparities in the National Institutes of Health funding for hematologic malignancies and cellular therapies
Raheel Sufian Siddiqui, Sibgha Gull Chaudhary, Moazzam Shahzad, Iqra Anwar, Ali Hussain, Nausheen Ahmed, Sunil Hari Abhyankar, Leyla Shune, Peiman Hematti, Heather Male, Faisal Khosa, Tara Lin, Joseph Patrick McGuirk, Natalie Scott Callander & Muhammad Umair Mushtaq
Pages: 1708-1713
Published online: 10 Feb 2022
AbstractforGender disparities in the National Institutes of Health funding for hematologic malignancies and cellular therapies | Full Text | References | PDF (825.3 KB) | EPUB
  • 317 Views
  • 2 CrossRef citations
  • 0Altmetric

Letters to Editor

Letter
Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia
Fadi Haddad, Hagop Kantarjian, Ghayas C. Issa, Elias Jabbour & Koji Sasaki
Pages: 1714-1717
Published online: 01 Apr 2022
First Page PreviewforIntracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia | Full Text | References | PDF (637 KB) | EPUB
  • 369 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Momelotinib reduces transfusion requirements in patients with myelofibrosis
Ruben Mesa, Stephen T. Oh, Aaron T. Gerds, Vikas Gupta, John Catalano, Francisco Cervantes, Timothy Devos, Marek Hus, Jean-Jacques Kiladjian, Ewa Lech-Maranda, Donal McLornan, Jeanne Palmer, Uwe Platzbecker, Jacek Treliński, Kazuya Shimoda, Rafe Donahue, Koenraad D’Hollander, Mark Kowalski & Srdan Verstovsek
Pages: 1718-1722
Published online: 07 Mar 2022
First Page PreviewforMomelotinib reduces transfusion requirements in patients with myelofibrosis | Full Text | References | PDF (923.6 KB) | EPUB
  • 3491 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Letter
COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experience
Neha Mehta-Shah, Nancy L. Bartlett, Brad Kahl, Marcus P. Watkins, Amalia Dubois, Gabby Schmelzle, Saiama Waqar, Claire Ballman, Fei Wan & Christopher W. Farnsworth
Pages: 1723-1727
Published online: 27 Feb 2022
First Page PreviewforCOVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experience | Full Text | References | PDF (973.4 KB) | EPUB | Supplemental
  • 415 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Phase 1/2 study of acalabrutinib and the PI3K delta inhibitor ACP-319 in relapsed/refractory B-cell Non-Hodgkin lymphoma
Paul M. Barr, Stephen D. Smith, Mark J. Roschewski, Susan M. O’Brien, Jeff P. Sharman, Jason M. Melear, Priti Patel, Roser Calvo, Helen Yang & Stephen E. Spurgeon
Pages: 1728-1732
Published online: 24 Feb 2022
First Page PreviewforPhase 1/2 study of acalabrutinib and the PI3K delta inhibitor ACP-319 in relapsed/refractory B-cell Non-Hodgkin lymphoma | Full Text | References | PDF (994.8 KB) | EPUB | Supplemental
  • 1755 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Letter
Wilms’ tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory malignant lymphoma
Masahiro Ogasawara, Mamiko Miyashita, Yuka Yamagishi & Shuichi Ota
Pages: 1733-1737
Published online: 15 Feb 2022
First Page PreviewforWilms’ tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory malignant lymphoma | Full Text | References | PDF (638.9 KB) | EPUB
  • 197 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
The addition of lopinavir-ritonavir to carfilzomib-based triplets can induce meaningful clinical response in carfilzomib-refractory myeloma patients: a single-center experience
Rory Bennett, Henry Chan, Ross Henderson, Eileen Merriman, Merit Hanna, Anna Elinder-Camburn & David Simpson
Pages: 1738-1741
Published online: 11 Feb 2022
First Page PreviewforThe addition of lopinavir-ritonavir to carfilzomib-based triplets can induce meaningful clinical response in carfilzomib-refractory myeloma patients: a single-center experience | Full Text | References | PDF (652.5 KB) | EPUB | Supplemental
  • 250 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Anticoagulant effects on the evaluation of CD23 expression in cells by monoclonal antibodies
Katsushi Tajima, Kiwa Tanaka, Hikaru Takeda, Mika Moriya, Tetsuya Ueki, Shinya Ogata, Kunihiko Maeda & Takeshi Yasuda
Pages: 1742-1745
Published online: 11 Feb 2022
First Page PreviewforAnticoagulant effects on the evaluation of CD23 expression in cells by monoclonal antibodies | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 134 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Variant t(11;22)(q13;q11.2) with IGL involvement in mantle cell lymphoma
Alba Cabirta, Gloria Hidalgo-Gómez, Ana Marín-Niebla, Laura Gallur, Silvia Saumell, Josep Castellví, Eva Catalá, Adoración Blanco, Laura López-Andreoni, María Julia Montoro, Mayda Navarrete, Carlos Palacio-García, Bárbara Tazón-Vega, Sabela Bobillo, Francesc Bosch & Margarita Ortega
Pages: 1746-1749
Published online: 07 Feb 2022
First Page PreviewforVariant t(11;22)(q13;q11.2) with IGL involvement in mantle cell lymphoma | Full Text | References | PDF (1.6 MB) | EPUB
  • 307 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma
David A. Bond, Ying Huang, Beth A. Christian, Samantha Jaglowski, Don Benson, Lapo Alinari, Robert A. Baiocchi, Jonathon B. Cohen, Kristie A. Blum & Kami J. Maddocks
Pages: 1750-1753
Published online: 06 Feb 2022
First Page PreviewforA phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma | Full Text | References | PDF (776.9 KB) | EPUB
  • 287 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Occult central nervous system involvement guides therapeutic choices in blastic plasmacytoid dendritic cell neoplasms
Elisa Buzzatti, Giovangiacinto Paterno, Raffaele Palmieri, Fabiana Esposito, Maria Rosaria Pascale, Flavia Mallegni, Luca Guarnera, Gianmario Pasqualone, Maria Antonietta Irno Consalvo, Daniela Fraboni, Federico Moretti, Arianna Savi, Beatrice Borsellino, Luca Maurillo, Francesco Buccisano, Giuseppe Sconocchia, Adriano Venditti & Maria Ilaria Del Principe
Pages: 1754-1757
Published online: 06 Mar 2022
First Page PreviewforOccult central nervous system involvement guides therapeutic choices in blastic plasmacytoid dendritic cell neoplasms | Full Text | References | PDF (678.5 KB) | EPUB
  • 204 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
A retrospective study of ultrahigh-risk (Mayo 2004 stage IIIb) AL amyloidosis and identification of predictors related to extremely early death
Ya-juan Gao, Kai-ni Shen, Hui-lei Miao, Zhuang Tian, Jun Feng, Lu Zhang, Xin-xin Cao, Dao-bin Zhou & Jian Li
Pages: 1758-1761
Published online: 02 Feb 2022
First Page PreviewforA retrospective study of ultrahigh-risk (Mayo 2004 stage IIIb) AL amyloidosis and identification of predictors related to extremely early death | Full Text | References | PDF (847.7 KB) | EPUB
  • 348 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Tagraxofusp as first-line treatment for blastic plasmacytoid dendritic cell neoplasm
Rocío Díaz Acedo, María Ángeles Domínguez Muñoz, Clara Navajas Laguna, Rosario Morales Camacho, Isabel Simón Pilo, Virgilio Pablo Calama Ruiz-Mateos, Manuel Yébenes Ramírez, María Vahí Sánchez de Medina, Silvia Artacho Criado, Aitana Rodríguez Pérez & María Carmen Couto Caro
Pages: 1762-1764
Published online: 24 Feb 2022
First Page PreviewforTagraxofusp as first-line treatment for blastic plasmacytoid dendritic cell neoplasm | Full Text | References | PDF (693.2 KB) | EPUB
  • 250 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Bone primary, spindle cell variant of diffuse large B-cell lymphoma presenting in the femur from a Paget’s disease patient
Wei Josephine Wang, Allen C. Omo-Ogboi, Xavier Rivera Rivera, Ali Mehdi Moosvi & Lei Chen
Pages: 1765-1767
Published online: 27 Feb 2022
First Page PreviewforBone primary, spindle cell variant of diffuse large B-cell lymphoma presenting in the femur from a Paget’s disease patient | Full Text | References | PDF (1.1 MB) | EPUB
  • 181 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Brentuximab vedotin-induced pancreatitis in lymphoma: a pharmacovigilance study
Donald C. Moore, Joseph B. Elmes, Scott A. Strassels & Jai N. Patel
Pages: 1768-1769
Published online: 06 Mar 2022
CitationforBrentuximab vedotin-induced pancreatitis in lymphoma: a pharmacovigilance study | Full Text | References | PDF (239.6 KB) | EPUB
  • 268 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Outcomes of patients aged ≥26 years with relapsed or refractory B-cell acute lymphoblastic leukemia in ZUMA-3 and historical trials
Monique C. Minnema et al.
Article | Published online: 24 May 2024
Open Access
Acceleration of non-Hodgkin lymphoma progression during pregnancy in a murine model
Netanel A. Horowitz et al.
Letter to the Editor | Published online: 23 May 2024
Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated CD79B, high TCL1A expression, or over- expressed MYC/BCL-2
Yang Liu et al.
Article | Published online: 22 May 2024
Open Access
Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia
Karolina Bełdzińska-Gądek et al.
Article | Published online: 22 May 2024
View all latest articles